Attorneys Keum Nang Park Named to Benchmark Litigation Asia-Pacific’s ‘Top 100 Women in Litigation 2026’

Lee & Ko Attorneys Keum Nang Park of the Healthcare Group have been named to Benchmark Litigation Asia-Pacific’s ‘Top 100 Women in Litigation 2026’ in recognition of their outstanding achievements in healthcare-related patent and regulatory disputes, as well as major competition law matters.

Ms. Park serves as Co-Head of Lee & Ko’s Healthcare Group, advising clients on intellectual property matters—including pharmaceutical and biotechnology patents—as well as a broad range of regulatory matters involving the Ministry of Health and Welfare, the Ministry of Food and Drug Safety, and the Ministry of Environment. She brings deep and wide-ranging expertise across the healthcare industry, including pharmaceuticals, medical devices, cosmetics, food, dietary supplements and household chemical products. Ms. Park was named to this year’s list in recognition of her success in defending market exclusivity on behalf of the patent holder of a world-renowned cardiovascular blockbuster drug, prevailing in more than 100 patent suits brought by numerous generic manufacturers. Her selection also reflects her achievements in protecting patent rights in litigation involving a widely used blockbuster biologic for chronic inflammatory disease and a prominent blockbuster biologic for ophthalmic disease.

Benchmark Litigation, published by Delinian, formerly Euromoney, is a globally renowned publication focusing on dispute resolution and litigation. Its annual ‘Top 100 Women in Litigation’ list recognizes 100 leading female litigators in the Asia-Pacific region based on months of in-depth research and analysis.